BCAL Diagnostics Limited (AU:BDX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
BCAL Diagnostics Limited is set to issue 12 million unlisted options as part of an employee incentive scheme. This move indicates the company’s strategic focus on retaining and motivating its workforce as it continues to grow. Investors may find this development promising for the company’s long-term potential.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.